XML 12 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 5,628,880 $ 4,084,085
Grants receivable 273,638 757,562
Prepaid expenses 339,176 419,751
Other current assets 0 47,586
Total current assets 6,241,694 5,308,984
Property and equipment, net 470,120 135,486
Goodwill 6,826,003 6,826,003
Other long term assets 148,597 126,654
Total assets 13,686,414 12,397,127
Current liabilities:    
Accounts payable 2,014,606 3,002,497
Accrued compensation 463,828 562,755
Accrued clinical operations and site costs 472,990 391,041
Accrued lease contingency fee 590,504 590,504
License fee payable 225,000 225,000
Other accrued expenses 450,873 186,566
Interest payable 50,437 0
Notes payable - capital leases 16,051 0
Total current liabilities 4,284,289 4,958,363
Long-term liabilities:    
Notes payable, net 3,980,437 0
Capital leases 79,605 0
Other long-term liabilities 102,863 0
Total long-term liabilities $ 4,162,905 $ 0
Commitments and contingencies:
Stockholders' equity:    
Common stock, $0.01 par value; 150,000,000 shares authorized, 29,311,272 and 28,391,072 shares issued and outstanding as of March 31, 2016 and December 31, 2015, respectively $ 293,113 $ 283,911
Additional paid-in capital 69,950,489 67,754,383
Accumulated deficit (65,006,548) (60,601,778)
Total stockholders' equity 5,239,220 7,438,764
Total liabilities and stockholders' equity 13,686,414 12,397,127
Series D Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock 1,833 1,915
Series E Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock $ 333 $ 333